摘要:
Crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one having a diffraction peak at a diffraction angle (2θ±0.2°) of 9.7° and/or 21.9° in a powder X-ray diffraction are suitable for an active ingredient of a preventing and therapeutic agent for diseases such as constipation. Crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one hydrate and amorphous 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one hydrate are also suitable for an active ingredient of a preventing and therapeutic agent for diseases such as constipation.
摘要:
Crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one having a diffraction peak at a diffraction angle (2θ±0.2°) of 12.8°, 18.1° and/or 23.5° in a powder X-ray diffraction are excellent in stability against light, therefore are suitable for an active ingredient of a preventing and therapeutic agent for diseases such as constipation.
摘要:
Crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one having a diffraction peak at a diffraction angle (2θ±0.2°) of 9.7° and/or 21.9° in a powder X-ray diffraction are suitable for an active ingredient of a preventing and therapeutic agent for diseases such as constipation. Crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one hydrate and amorphous 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one hydrate are also suitable for an active ingredient of a preventing and therapeutic agent for diseases such as constipation.
摘要:
Crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one having a diffraction peak at a diffraction angle (2θ±0.2°) of 9.7° and/or 21.9° in a powder X-ray diffraction are suitable for an active ingredient of a preventing and therapeutic agent for diseases such as constipation. Crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one hydrate and amorphous 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one hydrate are also suitable for an active ingredient of a preventing and therapeutic agent for diseases such as constipation.
摘要:
Crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one having a diffraction peak at a diffraction angle (2θ±0.2°) of 12.8°, 18.1° and/or 23.5° in a powder X-ray diffraction are excellent in stability against light, therefore are suitable for an active ingredient of a preventing and therapeutic agent for diseases such as constipation.
摘要:
To ensure easy and secure placement of a belt for KAATSU muscle training on a target compressed site near the proximal portion of a limb.A belt 100B has a longer first band-shaped member 110 and a shorter second band-shaped member 120 both of which have a band shape and are connected to a ring-shaped joint member 130 at their respective ends. In order to place the belt 100B on the target compressed site, the limb (right leg in this case) on which the belt 100B is expected to be placed is inserted into a loop of the first band-shaped member 110 formed by passing the end of the first band-shaped member 110 through an opening in the joint member 130, and the belt is moved up to the target compressed site. Then, the first band-shaped member 110 and the second band-shaped member 120 are pulled with both hands in the opposite directions. The belt 100B is placed on the target compressed site with the belt 100B being tensioned appropriately.
摘要:
A muscle building tool 1 is used to build, by applying a predetermined pressure to at least one of a user's four limbs to restrict blood flow, a muscle of the limb, and includes: a belt 10 that is wrapped around the at least one of the four limbs and applies the pressure to the muscle; a fastener 40 that maintains a loop shape of the belt 10 in a state of applying the pressure to the muscle; a tension sensor 60 that measures a tension acting on the belt 10 when wrapping the belt 10; and a pressure sensor that is configured to automatically start an operation when the tension measured by the tension sensor 60 exceeds a predetermined threshold, and measures the pressure applied to the muscle.
摘要:
An electronic apparatus having a display device, an operation section, an area setting section and a brightness adjuster is provided. The display device is configured to display an image and text. The operation section configured to be used for input operation. The area setting section is configured to set a noticed area on a screen displayed on the display device on the basis of an input operation done on the operation section. The brightness adjuster is configured to make an unnoticed area of the screen less bright than the noticed area.
摘要:
The present invention provides a pharmaceutical composition for ameliorating brain damage induced by oxygen deficiency, comprising a chondroitin sulfate-degrading enzyme and at least one of a neural stem cell(s) and a neural progenitor cell(s), as active ingredients.